Streetbeat News

Revenues

NRSN

NeuroSense Therapeutics Ltd. plans to submit a dossier for early commercialization of its ALS treatment, PrimeC, in Canada by Q2 2025, with a regulatory decision expected by Q1 2026. The company estimates a potential market opportunity of $100M-$150M in annual revenue.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 1:24 pm

HLIO

Helios Technologies, Inc. (NYSE:HLIO) is recovering from Hurricane Milton, which directly hit Sarasota, affecting its facilities. The company plans to provide estimates of the hurricane's impact on its Q4 financial projections when it reports Q3 2024 results. Two of its three Sun Hydraulics' manufacturing facilities have reopened six days after the hurricane.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 1:17 pm

RCAT

Red Cat Holdings has secured a $1 million contract for its FlightWave Edge 130 Blue drone, indicating potential growth and increased revenue for the company.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 1:17 pm

TTEK

Tetra Tech has secured a $37.5 million contract from USAID to provide urban water, sanitation, and solid waste management services. This contract highlights Tetra Tech's expertise in environmental and infrastructure services.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 1:11 pm

FOXO

FOXO Technologies shares rose after the interim CFO communicated plans to grow the business and achieve over $50 million in annual revenue within the next 12-24 months.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 1:10 pm

LOBO

LOBO EV Technologies reported a significant increase in deliveries and revenue for September 2024. Deliveries rose by 108% year-over-year, while revenue from overseas customers surged by 254% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 1:06 pm

PHAR

Pharming (NASDAQ:PHAR) has received consistent 'Buy' ratings from analysts, with a stable 12-month price target of $37.00. The company has shown a 34.97% revenue growth over the past three months, though its growth rate is below the healthcare sector average. Pharming's financial health is strong, with efficient cost management and a prudent debt strategy.

Portfolio Pulse from Benzinga Insights

October 15, 2024 | 1:00 pm

SDA

SunCar Technology Group has expanded its collaboration with ICBC Shaanxi Branch through the 'Shaanxi Benefits' platform, driving consumer spending over RMB 70 million (US$9.9 million) for the branch.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 1:00 pm

GPK

Analyst ratings for Graphic Packaging Holding (NYSE:GPK) show a mix of bullish and bearish perspectives, with recent price target adjustments indicating a positive trend. The company's financial performance reveals challenges in revenue growth and profitability, but a strong market position and healthy debt management.

Portfolio Pulse from Benzinga Insights

October 15, 2024 | 1:00 pm

SEE

Sealed Air (NYSE:SEE) has been analyzed by six analysts, showing a range of ratings from bullish to indifferent. The average 12-month price target has decreased by 8.8% to $38.67. Analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. Sealed Air's financial performance shows challenges in revenue growth and debt management, but strong return on equity.

Portfolio Pulse from Benzinga Insights

October 15, 2024 | 1:00 pm